vs

Side-by-side financial comparison of Dayforce (DAY) and INSMED Inc (INSM). Click either name above to swap in a different company.

Dayforce is the larger business by last-quarter revenue ($481.6M vs $263.8M, roughly 1.8× INSMED Inc). Dayforce runs the higher net margin — -40.9% vs -124.5%, a 83.6% gap on every dollar of revenue. On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs 9.5%). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs 9.8%).

Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

DAY vs INSM — Head-to-Head

Bigger by revenue
DAY
DAY
1.8× larger
DAY
$481.6M
$263.8M
INSM
Growing faster (revenue YoY)
INSM
INSM
+143.2% gap
INSM
152.6%
9.5%
DAY
Higher net margin
DAY
DAY
83.6% more per $
DAY
-40.9%
-124.5%
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
9.8%
DAY

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DAY
DAY
INSM
INSM
Revenue
$481.6M
$263.8M
Net Profit
$-196.8M
$-328.5M
Gross Margin
83.2%
Operating Margin
6.3%
-121.2%
Net Margin
-40.9%
-124.5%
Revenue YoY
9.5%
152.6%
Net Profit YoY
-9940.0%
-39.5%
EPS (diluted)
$-1.23
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAY
DAY
INSM
INSM
Q4 25
$263.8M
Q3 25
$481.6M
$142.3M
Q2 25
$464.7M
$107.4M
Q1 25
$481.8M
$92.8M
Q4 24
$465.2M
$104.4M
Q3 24
$440.0M
$93.4M
Q2 24
$423.3M
$90.3M
Q1 24
$431.5M
$75.5M
Net Profit
DAY
DAY
INSM
INSM
Q4 25
$-328.5M
Q3 25
$-196.8M
$-370.0M
Q2 25
$21.3M
$-321.7M
Q1 25
$14.9M
$-256.6M
Q4 24
$10.8M
$-235.5M
Q3 24
$2.0M
$-220.5M
Q2 24
$-1.8M
$-300.6M
Q1 24
$7.1M
$-157.1M
Gross Margin
DAY
DAY
INSM
INSM
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
47.0%
75.0%
Q3 24
45.8%
77.3%
Q2 24
44.1%
76.8%
Q1 24
47.6%
76.9%
Operating Margin
DAY
DAY
INSM
INSM
Q4 25
-121.2%
Q3 25
6.3%
-257.1%
Q2 25
9.1%
-291.3%
Q1 25
6.4%
-267.3%
Q4 24
6.1%
-220.6%
Q3 24
4.7%
-228.4%
Q2 24
3.3%
-319.8%
Q1 24
9.4%
-192.7%
Net Margin
DAY
DAY
INSM
INSM
Q4 25
-124.5%
Q3 25
-40.9%
-260.0%
Q2 25
4.6%
-299.5%
Q1 25
3.1%
-276.4%
Q4 24
2.3%
-225.5%
Q3 24
0.5%
-236.0%
Q2 24
-0.4%
-332.8%
Q1 24
1.6%
-208.1%
EPS (diluted)
DAY
DAY
INSM
INSM
Q4 25
$-1.55
Q3 25
$-1.23
$-1.75
Q2 25
$0.13
$-1.70
Q1 25
$0.09
$-1.42
Q4 24
$0.07
$-1.30
Q3 24
$0.01
$-1.27
Q2 24
$-0.01
$-1.94
Q1 24
$0.04
$-1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAY
DAY
INSM
INSM
Cash + ST InvestmentsLiquidity on hand
$627.6M
$1.4B
Total DebtLower is stronger
$631.1M
$546.8M
Stockholders' EquityBook value
$2.7B
$739.0M
Total Assets
$8.7B
$2.3B
Debt / EquityLower = less leverage
0.23×
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAY
DAY
INSM
INSM
Q4 25
$1.4B
Q3 25
$627.6M
$1.7B
Q2 25
$625.2M
$1.9B
Q1 25
$557.3M
$1.2B
Q4 24
$579.7M
$1.4B
Q3 24
$494.1M
$1.5B
Q2 24
$465.4M
$1.2B
Q1 24
$392.5M
$595.7M
Total Debt
DAY
DAY
INSM
INSM
Q4 25
$546.8M
Q3 25
$631.1M
$546.8M
Q2 25
$631.8M
$546.8M
Q1 25
$632.4M
$1.1B
Q4 24
$1.2B
$1.1B
Q3 24
$1.2B
$971.8M
Q2 24
$1.2B
$1.2B
Q1 24
$1.2B
$1.2B
Stockholders' Equity
DAY
DAY
INSM
INSM
Q4 25
$739.0M
Q3 25
$2.7B
$945.6M
Q2 25
$2.7B
$1.2B
Q1 25
$2.6B
$99.2M
Q4 24
$2.5B
$285.4M
Q3 24
$2.6B
$483.4M
Q2 24
$2.5B
$38.8M
Q1 24
$2.4B
$-464.8M
Total Assets
DAY
DAY
INSM
INSM
Q4 25
$2.3B
Q3 25
$8.7B
$2.4B
Q2 25
$8.5B
$2.5B
Q1 25
$9.5B
$1.8B
Q4 24
$9.1B
$2.0B
Q3 24
$8.1B
$2.1B
Q2 24
$9.0B
$1.8B
Q1 24
$10.8B
$1.2B
Debt / Equity
DAY
DAY
INSM
INSM
Q4 25
0.74×
Q3 25
0.23×
0.58×
Q2 25
0.23×
0.44×
Q1 25
0.24×
11.31×
Q4 24
0.47×
3.93×
Q3 24
0.47×
2.01×
Q2 24
0.49×
30.66×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAY
DAY
INSM
INSM
Operating Cash FlowLast quarter
$31.2M
$-247.6M
Free Cash FlowOCF − Capex
$-264.2M
FCF MarginFCF / Revenue
-100.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAY
DAY
INSM
INSM
Q4 25
$-247.6M
Q3 25
$31.2M
$-219.8M
Q2 25
$112.7M
$-205.6M
Q1 25
$49.6M
$-262.1M
Q4 24
$81.0M
$-196.0M
Q3 24
$91.8M
$-180.9M
Q2 24
$99.2M
$-123.0M
Q1 24
$9.1M
$-184.0M
Free Cash Flow
DAY
DAY
INSM
INSM
Q4 25
$-264.2M
Q3 25
$-222.2M
Q2 25
$-209.1M
Q1 25
$-272.2M
Q4 24
$-202.8M
Q3 24
$-184.6M
Q2 24
$-129.7M
Q1 24
$-188.7M
FCF Margin
DAY
DAY
INSM
INSM
Q4 25
-100.1%
Q3 25
-156.1%
Q2 25
-194.6%
Q1 25
-293.2%
Q4 24
-194.1%
Q3 24
-197.6%
Q2 24
-143.6%
Q1 24
-250.0%
Capex Intensity
DAY
DAY
INSM
INSM
Q4 25
6.3%
Q3 25
1.7%
Q2 25
3.2%
Q1 25
10.8%
Q4 24
6.5%
Q3 24
3.9%
Q2 24
7.5%
Q1 24
6.2%
Cash Conversion
DAY
DAY
INSM
INSM
Q4 25
Q3 25
Q2 25
5.29×
Q1 25
3.33×
Q4 24
7.50×
Q3 24
45.90×
Q2 24
Q1 24
1.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAY
DAY

Dayforce Recurring$333.0M69%
Cloud And Bureau Professional Services And Other$78.5M16%
Float$42.2M9%
Powerpay Recurring$19.7M4%
Other Recurring$8.2M2%

INSM
INSM

Segment breakdown not available.

Related Comparisons